Issues with the current drugs for Mycobacterium tuberculosis cure and potential of cell envelope proteins for new drug discovery

2021 Espinal, 2003, The global situation of MDR-TB, Tuberculosis, 83, 44, 10.1016/S1472-9792(02)00058-6 Horsburgh, 2015, Treatment of tuberculosis, N Engl J Med, 373, 2149, 10.1056/NEJMra1413919 Xu, 2014, Insights into battles between Mycobacterium tuberculosis and macrophages, Protein Cell, 5, 728, 10.1007/s13238-014-0077-5 Dulberger, 2020, The mycobacterial cell envelope — a moving target, Nat Rev Microbiol, 18, 47, 10.1038/s41579-019-0273-7 Geiman, 2006, Differential gene expression in response to exposure to antimycobacterial agents and other stress conditions among seven Mycobacterium tuberculosis whiB- like genes, Antimicrob Agents Chemother, 50, 2836, 10.1128/AAC.00295-06 Chan, 2017, Potential and use of bacterial small RNAs to combat drug resistance: a systematic review, Infect Drug Resist, 10, 521, 10.2147/IDR.S148444 Walter, 2015, Transcriptional adaptation of drug-tolerant Mycobacterium tuberculosis during treatment of human tuberculosis, J Infect Dis, 212, 990, 10.1093/infdis/jiv149 Zhang Y, Yew WW. Mechanisms of Drug Resistance in Mycobacterium tuberculosis: Update 2015. :15. Koch, 2018, Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment, Curr Opin Pharmacol, 42, 7, 10.1016/j.coph.2018.05.013 Roy, 2001, Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 “null” mutation, J Gastroenterol Hepatol, 16, 1033, 10.1046/j.1440-1746.2001.02585.x Jenner, 1994, Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo, Arch Toxicol, 68, 349, 10.1007/s002040050081 Connolly, 2007, Why is long-term therapy required to cure tuberculosis?, PLoS Med, 4, 10.1371/journal.pmed.0040120 Hoffmann, 2008, Disclosure of the mycobacterial outer membrane: cryo-electron tomography and vitreous sections reveal the lipid bilayer structure, Proc Natl Acad Sci USA, 105, 3963, 10.1073/pnas.0709530105 Bhat, 2017, Cell wall: a versatile fountain of drug targets in Mycobacterium tuberculosis, Biomed Pharmacother, 95, 1520, 10.1016/j.biopha.2017.09.036 Chatterjee, 1998, Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects, Glycobiology, 8, 113, 10.1093/glycob/8.2.113 Jackson, 2014, The mycobacterial cell envelope–lipids, Cold Spring Harb Perspect Med, 4, 10.1101/cshperspect.a021105 Maitra, 2019, Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles' heel for the TB-causing pathogen, FEMS Microbiol Rev, 43, 548, 10.1093/femsre/fuz016 Chiaradia, 2017, Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane, Sci Rep, 7, 10.1038/s41598-017-12718-4 Kalscheuer, 2019, The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis, Biochem J, 476, 1995, 10.1042/BCJ20190324 Holzheimer, 2021, Chemical synthesis of cell wall constituents of Mycobacterium tuberculosis, Chem Rev, 121, 9554, 10.1021/acs.chemrev.1c00043 Chawla, 2014, Protein kinase B (PknB) of Mycobacterium tuberculosis is essential for growth of the pathogen in vitro as well as for survival within the host, J Biol Chem, 289, 13858, 10.1074/jbc.M114.563536 Gupta, 2017, PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis, Ann Clin Microbiol Antimicrob, 16, 56, 10.1186/s12941-017-0234-9 Barthe, 2010, The structure of PknB extracellular PASTA domain from Mycobacterium tuberculosis suggests a ligand-dependent kinase activation, Structure, 18, 606, 10.1016/j.str.2010.02.013 Appunni, 2017, Targeting PknB, an eukaryotic-like serine/threonine protein kinase of Mycobacterium tuberculosis with phytomolecules, Comput Biol Chem, 67, 200, 10.1016/j.compbiolchem.2017.01.003 Chalut, 2016, MmpL transporter-mediated export of cell-wall associated lipids and siderophores in mycobacteria, Tuberculosis, 100, 32, 10.1016/j.tube.2016.06.004 Zhang, 2019, Crystal structures of membrane transporter MmpL3, an anti-TB drug target, Cell, 176, 636, 10.1016/j.cell.2019.01.003 Degiacomi, 2017, Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression, Sci Rep, 7, 10.1038/srep43495 Belisle, 1997, Role of the major antigen of M. tuberculosis in cell wall biogenesis, Science, 276, 1420, 10.1126/science.276.5317.1420 Hübscher, 2008, Phylogenetic distribution and membrane topology of the LytR-CpsA-Psr protein family, BMC Genom, 9, 617, 10.1186/1471-2164-9-617 Köster, 2018, Why macrophages cannot LAP up TB, Autophagy, 14, 552, 10.1080/15548627.2018.1425054 Amin, 2008, EmbA is an essential arabinosyltransferase in Mycobacterium tuberculosis, Microbiology, 154, 240, 10.1099/mic.0.2007/012153-0 Alderwick, 2011, The C-terminal domain of the arabinosyltransferase Mycobacterium tuberculosis EmbC is a lectin-like carbohydrate binding module, PLoS Pathog, 7, 10.1371/journal.ppat.1001299 Xu, 2017, A novel protein kinase inhibitor IMB-YH-8 with anti-tuberculosis activity, Sci Rep, 7, 5093, 10.1038/s41598-017-04108-7 Naqvi, 2014, Design, synthesis and molecular docking of substituted 3-hydrazinyl-3-oxo-propanamides as anti-tubercular agents, Bioorg Med Chem Lett, 24, 5181, 10.1016/j.bmcl.2014.09.080 Wehenkel, 2006, The structure of PknB in complex with mitoxantrone, an ATP-competitive inhibitor, suggests a mode of protein kinase regulation in mycobacteria, FEBS Lett, 580, 3018, 10.1016/j.febslet.2006.04.046 Lougheed, 2011, Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents, Tuberculosis, 91, 277, 10.1016/j.tube.2011.03.005 Antunes, 2021, Natural products from Brazilian biodiversity identified as potential inhibitors of PknA and PknB of M. tuberculosis using molecular modeling tools, Comput Biol Med, 136, 10.1016/j.compbiomed.2021.104694 Székely, 2008, A novel drug discovery concept for tuberculosis: inhibition of bacterial and host cell signalling, Immunol Lett, 116, 225, 10.1016/j.imlet.2007.12.005 Li, 2014, Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis, Antimicrob Agents Chemother, 58, 6413, 10.1128/AAC.03229-14 Li, 2016, Therapeutic potential of the M. tuberculosis mycolic acid transporter, MmpL3. Antimicrob Agents Chemother, 60, 5198, 10.1128/AAC.00826-16 Grover, 2021, Two-way regulation of MmpL3 expression identifies and validates inhibitors of MmpL3 function in M. tuberculosis, ACS Infect Dis, 7, 141, 10.1021/acsinfecdis.0c00675 Onajole, 2013, Preliminary structure–activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains, J Med Chem, 56, 4093, 10.1021/jm4003878 Shao, 2020, MmpL3 inhibitors as antituberculosis drugs, Eur J Med Chem, 200, 10.1016/j.ejmech.2020.112390 Deidda, 1998, Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic M. tuberculosis strains, Antimicrob Agents Chemother, 42, 3035, 10.1128/AAC.42.11.3035 Gahoi, 2013, Computational screening for new inhibitors of M. tuberculosis mycolyltransferases antigen 85 group of proteins as potential drug targets, J Biomol Struct Dyn, 31, 30, 10.1080/07391102.2012.691343 Nguyen, 2017, Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis, Sci Rep, 7, 10.1038/s41598-017-11843-4 Pant, 2020, Identification of potential mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via virtual high throughput screening and binding free energy studies, J Mol Graph Model, 98, 10.1016/j.jmgm.2020.107584 Heifets, 1986, Ethambutol MICs and MBCs for mycobacterium avium complex and Mycobacterium tuberculosis, Antimicrob Agents Chemother, 30, 927, 10.1128/AAC.30.6.927 Miryala, 2021, Identification of bioactive natural compounds as efficient inhibitors against M. tuberculosis protein-targets: a molecular docking and molecular dynamics simulation study, J Mol Liq, 341, 10.1016/j.molliq.2021.117340